The Garvan Institute is a leader in medical research in Australia and in the world, fostering breakthrough research in key therapeutic areas: cancer, immunology, neurology, diabetes and obesity and musculoskeletal diseases.
We have a strong history of both scientific and commercial collaboration with industry and some of our discoveries have been cornerstone technologies leading to the formation of new companies. These include G2 Therapies Pty Ltd and AZA Research Pty Ltd.
Our approach to partnering is flexible and commercially-focused. We recognise the essential role industry plays in pharmaceutical and diagnostic R&D and its importance in enabling us to achieve our goals of preventing and curing human disease.
We work with industry in different ways – through licensing our intellectual property, engaging in collaborative R&D projects or performing contract research, and provide companies with access to world-leading expertise and facilities.